Types and Distribution of Payments From Industry to Physicians in 2015
- PMID: 28464140
- PMCID: PMC5470350
- DOI: 10.1001/jama.2017.3091
Types and Distribution of Payments From Industry to Physicians in 2015
Abstract
Importance: Given scrutiny over financial conflicts of interest in health care, it is important to understand the types and distribution of industry-related payments to physicians.
Objective: To determine the types and distribution of industry-related payments to physicians in 2015 and the association of physician specialty and sex with receipt of payments from industry.
Design, setting, and participants: Observational, retrospective, population-based study of licensed US physicians (per National Plan & Provider Enumeration System) linked to 2015 Open Payments reports of industry payments. A total of 933 295 allopathic and osteopathic physicians. Outcomes were compared across specialties (surgery, primary care, specialists, interventionalists) and between 620 166 male (66.4%) and 313 129 female (33.6%) physicians using regression models adjusting for geographic Medicare-spending region and sole proprietorship.
Exposures: Physician specialty and sex.
Main outcomes and measures: Reported physician payment from industry (including nature, number, and value), categorized as general payments (including consulting fees and food and beverage), ownership interests (including stock options, partnership shares), royalty or license payments, and research payments. Associations between physician characteristics and reported receipt of payment.
Results: In 2015, 449 864 of 933 295 physicians (133 842 [29.8%] women), representing approximately 48% of all US physicians were reported to have received $2.4 billion in industry payments, including approximately $1.8 billion for general payments, $544 million for ownership interests, and $75 million for research payments. Compared with 47.7% of primary care physicians (205 830 of 431 819), 61.0% of surgeons (110 604 of 181 372) were reported as receiving general payments (absolute difference, 13.3%; 95% CI, 13.1-13.6; odds ratio [OR], 1.72; P < .001). Surgeons had a mean per-physician reported payment value of $6879 (95% CI, $5895-$7862) vs $2227 (95% CI, $2141-$2314) among primary care physicians (absolute difference, $4651; 95% CI, $4014-$5288). After adjusting for geographic spending region and sole proprietorship, men within each specialty had a higher odds of receiving general payments than did women: surgery, 62.5% vs 56.5% (OR, 1.28; 95% CI, 1.26-1.31); primary care, 50.9% vs 43.0% (OR, 1.38; 95% CI, 1.36-1.39); specialists, 36.3% vs 33.4% (OR, 1.15; 95% CI, 1.13-1.17); and interventionalists, 58.1% vs 40.7% (OR, 2.03; 95% CI, 1.97-2.10; P < .001 for all tests). Similarly, men reportedly received more royalty or license payments than did women: surgery, 1.2% vs 0.03% (OR, 43.20; 95% CI, 25.02-74.57); primary care, 0.02% vs 0.002% (OR, 9.34; 95% CI, 4.11-21.23); specialists, 0.08% vs 0.01% (OR, 3.67; 95% CI, 1.71-7.89); and for interventionalists, 0.13% vs 0.04% (OR, 7.98; 95% CI, 2.87-22.19; P < .001 for all tests).
Conclusions and relevance: According to data from 2015 Open Payments reports, 48% of physicians were reported to have received a total of $2.4 billion in industry-related payments, primarily general payments, with a higher likelihood and higher value of payments to physicians in surgical vs primary care specialties and to male vs female physicians.
Conflict of interest statement
Comment in
-
Re: Types and Distribution of Payments from Industry to Physicians in 2015.J Urol. 2017 Nov;198(5):971-972. doi: 10.1016/j.juro.2017.08.061. Epub 2017 Aug 16. J Urol. 2017. PMID: 29059760 No abstract available.
Similar articles
-
Distribution and Patterns of Industry-Related Payments to Oncologists in 2014.J Natl Cancer Inst. 2016 Jul 7;108(12):djw163. doi: 10.1093/jnci/djw163. Print 2016 Dec. J Natl Cancer Inst. 2016. PMID: 27389914 Free PMC article.
-
Association between physician characteristics and payments from industry in 2015-2017: observational study.BMJ Open. 2019 Sep 20;9(9):e031010. doi: 10.1136/bmjopen-2019-031010. BMJ Open. 2019. PMID: 31542759 Free PMC article.
-
Evaluation of Sex Distribution of Industry Payments Among Radiation Oncologists.JAMA Netw Open. 2019 Jan 4;2(1):e187377. doi: 10.1001/jamanetworkopen.2018.7377. JAMA Netw Open. 2019. PMID: 30681710 Free PMC article.
-
Disclosure of Industry Payments to Physicians: An Epidemiologic Analysis of Early Data From the Open Payments Program.Mayo Clin Proc. 2016 Jan;91(1):84-96. doi: 10.1016/j.mayocp.2015.10.016. Mayo Clin Proc. 2016. PMID: 26763512 Free PMC article. Review.
-
Industry Compensation to Physician Vascular Specialist Authors of Highly-referenced Aortic Aneurysm Studies.Ann Vasc Surg. 2021 Jul;74:410-418. doi: 10.1016/j.avsg.2021.01.103. Epub 2021 Apr 2. Ann Vasc Surg. 2021. PMID: 33819597 Review.
Cited by
-
Contemporary Analysis of Inconsistencies Between Physician-reported Disclosures at the AAOS Annual Meeting and Industry-reported Financial Disclosures in the Open Payments Database.J Am Acad Orthop Surg Glob Res Rev. 2022 Jul 6;6(7):e22.00048. doi: 10.5435/JAAOSGlobal-D-22-00048. eCollection 2022 Jul 1. J Am Acad Orthop Surg Glob Res Rev. 2022. PMID: 35794724 Free PMC article.
-
Association of Pharmaceutical Industry Marketing of Opioid Products With Mortality From Opioid-Related Overdoses.JAMA Netw Open. 2019 Jan 4;2(1):e186007. doi: 10.1001/jamanetworkopen.2018.6007. JAMA Netw Open. 2019. PMID: 30657529 Free PMC article.
-
Pharmaceutical Payments to Japanese Board-Certified Infectious Disease Specialists: A Four-Year Retrospective Analysis of Payments from 92 Pharmaceutical Companies between 2016 and 2019.Int J Environ Res Public Health. 2022 Jun 16;19(12):7417. doi: 10.3390/ijerph19127417. Int J Environ Res Public Health. 2022. PMID: 35742661 Free PMC article.
-
Unsolicited Patient Complaints and Industry Payments for US Physicians.JAMA Netw Open. 2025 Aug 1;8(8):e2526643. doi: 10.1001/jamanetworkopen.2025.26643. JAMA Netw Open. 2025. PMID: 40762911 Free PMC article.
-
Pharmaceutical company payments to dermatology Clinical Practice Guideline authors in Japan.PLoS One. 2020 Oct 13;15(10):e0239610. doi: 10.1371/journal.pone.0239610. eCollection 2020. PLoS One. 2020. PMID: 33048952 Free PMC article.
References
-
- Campbell EG, Gruen RL, Mountford J, Miller LG, Cleary PD, Blumenthal D. A national survey of physician-industry relationships. N Engl J Med. 2007;356(17):1742-1750. - PubMed
-
- DeJong C, Aguilar T, Tseng C-W, Lin GA, Boscardin WJ, Dudley RA. Pharmaceutical industry-sponsored meals and physician prescribing patterns for Medicare beneficiaries. JAMA Intern Med. 2016;176(8):1114-10. - PubMed
-
- Lo B, Field MJ. Conflict of Interest in Medical Research, Education, and Practice. Washington, DC: National Academies Press; 2009. - PubMed
-
- Rosenthal MB, Mello MM. Sunlight as disinfectant—new rules on disclosure of industry payments to physicians. N Engl J Med. 2013;368(22):2052-2054. - PubMed
-
- Centers for Medicare & Medicaid Services Medicare, Medicaid, Children’s Health Insurance Programs; transparency reports and reporting of physician ownership or investment interests. Fed Regist. 2013;78(27):9457-9528. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources